Holen Sie sich die Stockscreener-App
30.56
1.40%
-0.2625
Schlusskurs vom Vortag:
$30.82
Offen:
$30.57
24-Stunden-Volumen:
60,186
Relative Volume:
0.08
Marktkapitalisierung:
$1.34B
Einnahmen:
$596.57M
Nettoeinkommen (Verlust:
$-109.88M
KGV:
-7.8876
EPS:
-3.8741
Netto-Cashflow:
$28.72M
1W Leistung:
-4.22%
1M Leistung:
-5.15%
6M Leistung:
+31.39%
1J Leistung:
+3.23%
1-Tages-Spanne:
$30.10
$30.57
1-Wochen-Bereich:
$30.10
$32.44
52-Wochen-Spanne:
$15.93
$41.73
Azenta Inc Stock (AZTA) Company Profile
Firmenname
Azenta Inc
Sektor
Telefon
(978) 262-2400
Adresse
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
30.57 | 1.35B | 596.57M | -109.88M | 28.72M | -3.8741 |
ISRG
Intuitive Surgical Inc
|
352.23 | 123.70B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
180.45 | 48.78B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
69.03 | 33.41B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.41 | 31.89B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.72 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-19 | Bestätigt | Needham | Buy |
| 2025-10-30 | Hochstufung | Jefferies | Hold → Buy |
| 2025-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Equal-Weight |
| 2024-12-18 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | Eingeleitet | Jefferies | Hold |
| 2024-02-01 | Bestätigt | B. Riley Securities | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-31 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-03-21 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Azenta Inc Aktie (AZTA) Neueste Nachrichten
Azenta Completes B Medical Divestiture With Loan Repayment - The Globe and Mail
Azenta Secures Full $35M Vendor Loan Repayment from B Medical Buyer Ahead of Schedule - Kalkine Media
Azenta completes B Medical sale as vendor loan repaid (AZTA) - Seeking Alpha
Azenta receives full $35M vendor loan repayment, completing $63M sale of B Medical Systems. - Pluang
Azenta Receives Full $35 Million Vendor Loan Repayment From B Medical Sale - citybiz.co
Azenta receives full $35.37M repayment, completes $63M sale of B Medical Systems - TradingView
A $63 million sale is now fully paid in cash. Azenta received the final $35 million. - Stock Titan
Azenta CEO resignation sparks 12% stock drop am... - Pluang
How Investors Are Reacting To Azenta (AZTA) CEO Resignation And Interim Leadership Change - simplywall.st
Azenta CEO Resigns as Interim Leader Reassures Outlook - The Globe and Mail
Why Azenta (AZTA) Stock Is Down Today - Barchart.com
Azenta CEO John Marotta Steps Down; Dr. Martin Madaus Named Interim CEO - Kalkine Media
Azenta appoints interim CEO as John Marotta resigns By Investing.com - Investing.com Nigeria
Azenta Names Martin Madaus Interim CEO, Reaffirms Revenue Guidance - citybiz.co
AZENTA ANNOUNCES LEADERSHIP TRANSITION - marketscreener.com
ETFs Investing in Azenta, Inc. Stocks - TradingView
Azenta (AZTA) Results Check: EPS Beats Its Estimate for the Current Session; Price Move: Shares Move Lower 1.79% in the Available RecordNew Analyst Coverage - vinanet.vn
Azenta, Inc. Earnings Call Balances Growth And Strain - The Globe and Mail
Azenta, Inc.: Financial Data Forecasts Estimates and Expectations | BA3 | US1143401024 - marketscreener.com
Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue (NASDAQ:AZTA) - Seeking Alpha
AZTA Q2 2026 Earnings: EPS Surpasses Estimates by 37.8% on Operational StrengthReturn On Equity - vinanet.vn
Azenta, Inc. (AZTA) Stock Forecasts - Yahoo Finance
Azenta Inc. (AZTA) Edges Higher to $33.53 as Life Sciences Tools Sector StabilizesExhaustion Gap - vinanet.vn
The 5 Most Interesting Analyst Questions From Azenta’s Q2 Earnings Call - Yahoo! Finance Canada
Azenta (AZTA) Is Up 11.5% After Returning To Profit And Raising Revenue OutlookHas The Bull Case Changed? - webull.com
Azenta (AZTA) SVP Pirogova has 1,085 shares withheld for tax obligations - Stock Titan
Azenta, Inc. Announces Appointment of Erik J. Bello as Chief Accounting Officer, Effective August 31, 2026 - marketscreener.com
Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector with a 4.41% Potential Upside - DirectorsTalk Interviews
AZTA Q2 2026 Earnings: EPS Surges 37.8% Above ExpectationsFiscal Year Earnings - vinanet.vn
Weekly Recap: Azenta, Inc. Q3 revenue gain and analyst target raises - TradingView
Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues - The National Law Review
Azenta Inc (AZTA) Stock News Today - TradingKey
Azenta, Inc. $AZTA Stake Cut by Quantinno Capital Management LP - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Azenta, Inc. (AZTA) And Encourages Investors to Connect - The National Law Review
Azenta (AZTA) Is Up 6.7% After Raising 2026 Guidance And Completing $50M Buyback – What’s Changed - Yahoo Finance
Multi-Manager Small Cap Equity Strategies Fund's Azenta Inc(AZTA) Holding History - GuruFocus
Azenta, Inc. 3Q 2026: Revenue $161.18M, EPS $0.05— 10-Q Summary - TradingView
Azenta (Nasdaq: AZTA) sells B Medical unit, books $149M impairment - Stock Titan
Life Science Funding Weakness Hit Azenta’s (AZTA) Outlook - Yahoo Finance
Azenta, Inc. $AZTA Shares Sold by Bank of New York Mellon Corp - MarketBeat
Arrowstreet Capital Limited Partnership Buys New Position in Azenta, Inc. $AZTA - MarketBeat
Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Gr - GuruFocus
Azenta, Inc. Stock 12‑Month Price Target Raised to $33.8, Implies 12% Upside - TradingView
Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Growth Surges 9% Amid Strategic ... - Yahoo Finance
Azenta Releases Q3 2026 Financial Results - AlphaStreet
Azenta (NASDAQ:AZTA) Price Target Raised to $37.00 - MarketBeat
Earnings call transcript: Azenta tops Q3 2026 estimates, shares edge higher - Investing.com
Transcript : Azenta, Inc., Q3 2026 Earnings Call, Aug 05, 2026 - marketscreener.com
Azenta Q3 Earnings Call Highlights - MarketBeat
Azenta, Inc. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:AZTA) 2026-08-05 - Seeking Alpha
Finanzdaten der Azenta Inc-Aktie (AZTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Azenta Inc-Aktie (AZTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cornog William L | Director |
May 18 '26 |
Buy |
16.38 |
10,000 |
163,800 |
19,703 |
| Marotta John | President and CEO |
Sep 10 '25 |
Sale |
29.41 |
316 |
9,294 |
105,980 |
1.12%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):